The complex landscape of microRNAs in articular cartilage: biology, pathology, and therapeutic targets

JCI Insight. 2018 Sep 6;3(17):e121630. doi: 10.1172/jci.insight.121630.

Abstract

The disabling degenerative disease osteoarthritis (OA) is prevalent among the global population. Articular cartilage degeneration is a central feature of OA; therefore, a better understanding of the mechanisms that maintain cartilage homeostasis is vital for developing effective therapeutic interventions. MicroRNAs (miRs) modulate cell signaling pathways and various processes in articular cartilage via posttranscriptional repression of target genes. As dysregulated miRs frequently alter the homeostasis of articular cartilage, modulating select miRs presents a potential therapeutic opportunity for OA. Here, we review key miRs that have been shown to modulate cartilage-protective or -destructive mechanisms and signaling pathways. Additionally, we use an integrative computational biology approach to provide insight into predicted miR gene targets that may contribute to OA pathogenesis, and highlight the complexity of miR signaling in OA by generating both unique and overlapping gene targets of miRs that mediate protective or destructive effects. Early OA detection would enable effective prevention; thus, miRs are being explored as diagnostic biomarkers. We discuss these ongoing efforts and the applicability of miR mimics and antisense inhibitors as potential OA therapeutics.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Apoptosis
  • Autophagy
  • Biomarkers
  • Cartilage, Articular / metabolism*
  • Cartilage, Articular / pathology
  • Chondrocytes / metabolism
  • Computational Biology
  • Genes, Overlapping
  • Homeostasis
  • Humans
  • MicroRNAs / blood
  • MicroRNAs / genetics
  • MicroRNAs / metabolism*
  • MicroRNAs / urine
  • Osteoarthritis / pathology
  • Osteoarthritis / therapy*
  • Signal Transduction
  • Synovial Membrane
  • Transcription Factors

Substances

  • Biomarkers
  • MicroRNAs
  • Transcription Factors

Grants and funding